Markets
U.S. open in 40 hrs, 31 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Medicines Co. gets positive EU panel result
AP ONLINE
posted: 36 DAYS 7 HOURS AGO
PARSIPPANY, N.J. (AP) — The Medicines Co. said Friday a European Union panel recommended approval for its anti-clotting agent Angiox for patients who are having an angioplasty following a heart attack.
The Committee for Medicinal Products for Human Use said the drug's approval should be broadened, The Medicines Co. said. The European Medicines Agency will make a final decision on the potential approval. In the U.S., the drug is sold under the name Angiomax.
Angiox is approved for use in patients having a coronary angioplasty, which clears blood flow around the heart, and as a treatment for patients with acute heart disease before surgery.
In morning trading, Medicines Co. shares lost 27 cents, or 3 percent, to $8.77.
COMMENTS ( 0 )